Thermo Fisher Scientific expands its SARS-CoV-2 testing portfolio in India with a point-of-care testing platform

The Accula System is an innovative platform that will accelerate the availability of reliable and accurate advanced molecular diagnostics at the point of care.

Mumbai (Maharashtra) [India], June 15: Thermo Fisher Scientific today announced the introduction of the new and innovative Accula SARS-CoV-2 Test that delivers gold-standard reverse transcription-polymerase chain reaction (RT-PCR) detection of SARS-CoV-2 in a point-of-care format.

The Accula SARS-CoV-2 Test has received Emergency Use Authorization (EUA) from the United States (U.S.) Food and Drug Administration (FDA) for the detection of SARS-CoV-2 in Clinical Laboratory Improvement Amendments (CLIA)–waived environments.

“Since the start of the pandemic, Thermo Fisher has acted quickly to provide support to the scientists and healthcare professionals at the frontlines of combating COVID-19,” said Amit Chopra, Managing Director, India, and South Asia, Thermo Fisher Scientific. “Thermo Fisher’s new testing platform combines the accuracy of RT-PCR with the simplicity, convenience, and procedural familiarity of traditional rapid immunoassays. The Accula SARS-CoV-2 Test is a natural extension to our existing offerings and will significantly help to meet the continuing demands for rapid and reliable COVID-19 testing in India.”

RT-PCR testing is streamlined from start to finish using a fully integrated, single-use microfluidic test cassette and the reusable, palm-sized Accula Dock. The test uses nasal swab samples and provides reliable, qualitative results in approximately 30 minutes. The Accula SARS-CoV-2 Test is enabled by proprietary PCR technology that allows for reduced absolute temperatures and reduced temperature differentials—resulting in rapid exponential amplification while reducing overall thermocycling times.

“The rapid Accula point-of-care test will open new avenues of personal and public testing without compromising on accuracy,” added Amit. “The introduction of the test in India is a demonstration of the impact our solutions have on human health during the pandemic, and far beyond.”

In January 2021, Thermo Fisher acquired Mesa Biotech Inc., which developed the Accula SARS-CoV-2 Test to provide accurate and faster results at the point of care.

For more information, please visit www.thermofisher.com

Thermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue exceeding $30 billion. Our Mission is to enable our customers to make the world healthier, cleaner, and safer. Whether our customers are accelerating life sciences research, solving complex analytical challenges, improving patient diagnostics and therapies, or increasing productivity in their laboratories, we are here to support them. Our global team of more than 80,000 colleagues delivers an unrivaled combination of innovative technologies, purchasing convenience, and pharmaceutical services through our industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, and Patheon.

Related Posts

  • Health
  • December 9, 2024
  • 34 views
UAE’s Mulk International & Ajeenkya DY Patil Group Partner To Launch Virtual Hospital Worth Dh100m

Dubai [UAE], December 9: In a landmark collaboration, Mulk International from the UAE and India’s Ajeenkya DY Patil Group have acquired stakes in Mulk Med Healthcare to become equal shareholders…

  • Health
  • December 3, 2024
  • 39 views
Dr. V.V. Manjula Kumari Honoured with Karmaveer Global Fellowship and Gold Medal

Guntur (Andhra Pradesh) [India], December 03: Dr. V.V. Manjula Kumari, a resident of Nellore, Andhra Pradesh, received the esteemed REX Karmaveer Global Fellowship and the Karmaveer Chakra Gold Medal Award…

You Missed

Arrow Greentech Ltd. Showcases Sustainable Water-Soluble Film Innovation at ICSCE Buyer-Seller Meet 2025

  • By
  • February 10, 2025
Arrow Greentech Ltd. Showcases Sustainable Water-Soluble Film Innovation at ICSCE Buyer-Seller Meet 2025

Waste Crisis Exposed: Are We Ignoring the Reality?

  • By
  • February 7, 2025
Waste Crisis Exposed: Are We Ignoring the Reality?

Yog Yatra: A Journey of Unity and Transformation

  • By
  • February 7, 2025
Yog Yatra: A Journey of Unity and Transformation

Global Coffee Chain Makes Indian Debut: Jamaica Craft Cafe Opens Premier Outlet at Motia Guildford Square

  • By
  • February 5, 2025
Global Coffee Chain Makes Indian Debut: Jamaica Craft Cafe Opens Premier Outlet at Motia Guildford Square

4th Bollywood Maha Arogya Shivir successfully organised Doctor 365 and RK HIV AIDS Research and Care Centre

  • By
  • February 5, 2025
4th Bollywood Maha Arogya Shivir successfully organised  Doctor 365 and RK HIV AIDS Research and Care Centre

No MBA, No Corporate Experience Just Execution: How These 20-Year-Olds Made It Big

  • By
  • February 3, 2025
No MBA, No Corporate Experience Just Execution: How These 20-Year-Olds Made It Big